Commentary: Omalizumab for the treatment of chronic idiopathic or spontaneous urticaria.

A PHP Error was encountered

Severity: Warning

Message: file_get_contents(https://...@pubfacts.com&api_key=b8daa3ad693db53b1410957c26c9a51b4908&a=1): Failed to open stream: HTTP request failed! HTTP/1.1 429 Too Many Requests

Filename: helpers/my_audit_helper.php

Line Number: 176

Backtrace:

File: /var/www/html/application/helpers/my_audit_helper.php
Line: 176
Function: file_get_contents

File: /var/www/html/application/helpers/my_audit_helper.php
Line: 250
Function: simplexml_load_file_from_url

File: /var/www/html/application/helpers/my_audit_helper.php
Line: 3122
Function: getPubMedXML

File: /var/www/html/application/controllers/Detail.php
Line: 575
Function: pubMedSearch_Global

File: /var/www/html/application/controllers/Detail.php
Line: 489
Function: pubMedGetRelatedKeyword

File: /var/www/html/index.php
Line: 316
Function: require_once

Commentary: Omalizumab for the treatment of chronic idiopathic or spontaneous urticaria. | LitMetric

Commentary: Omalizumab for the treatment of chronic idiopathic or spontaneous urticaria.

R A Sabroe

Br J Dermatol

Royal Hallamshire Hospital, Sheffield Teaching Hospitals NHS Foundation Trust, Glossop Road, Sheffield, S10 2JF, U.K.

Published: July 2014

Download full-text PDF
Source

http://dx.doi.org/10.1111/bjd.13074 DOI Listing

Download full-text PDF	Source
http://dx.doi.org/10.1111/bjd.13074	DOI Listing

Publication Analysis

Top Keywords

commentary omalizumab

omalizumab treatment

treatment chronic

chronic idiopathic

idiopathic spontaneous

spontaneous urticaria

commentary

treatment

chronic

idiopathic

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!